Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases

Shiva Badiee, Benjamin L. Franc, Emily M. Webb, Bill Chu, Randall A. Hawkins, Fergus Coakley

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

OBJECTIVE. The purpose of our study was to investigate the role of IV iodinated contrast material in the evaluation of hepatic metastases at 18F-FDG PET/CT. MATERIALS AND METHODS. We retrospectively identified 39 patients (25 men and 14 women) with suspected isolated hepatic metastases from colorectal cancer who underwent FDG PET/CT. The CT protocol included acquisition of unenhanced and multiphase contrast-enhanced CT images through the liver. At two separate sittings, four readers (two radiologists and two nuclear medicine physicians) noted and characterized all hepatic lesions in consensus, first based on PET and unenhanced CT images and later based on PET and contrast-enhanced CT images. The nature of detected lesions was established by histopathologic or clinicoradiologic correlation. RESULTS. A total of 178 hepatic lesions were identified, consisting of 137 metastases and 41 benign lesions. Using lesion-based analyses with Obuchowski's method for paired observations, 172 of 178 lesions (97%) were detected at PET/contrast-enhanced CT compared with only 135 of 178 (76%) at PET/unenhanced CT (p = 0.0004). Specifically, 114 of 137 (83%) hepatic metastases were detected on PET/contrast-enhanced CT compared with 92 of 137 (67%) on PET/unenhanced CT (p = 0.012). One hundred thirty-one of 178 lesions (73%) were accurately characterized at PET/contrast-enhanced CT compared with 101 of 178 (57%) at PET/unenhanced CT (p = 0.004). CONCLUSION. IV iodinated contrast material administration improves the detection of hepatic metastases and the characterization of focal hepatic lesions at PET/CT.

Original languageEnglish (US)
Pages (from-to)1436-1439
Number of pages4
JournalAmerican Journal of Roentgenology
Volume191
Issue number5
DOIs
StatePublished - Nov 2008
Externally publishedYes

Fingerprint

Fluorodeoxyglucose F18
Contrast Media
Neoplasm Metastasis
Liver
Nuclear Medicine
Colorectal Neoplasms
Physicians

Keywords

  • F-FDG
  • Colorectal cancer
  • Liver
  • Metastatic liver disease
  • PET/CT

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases. / Badiee, Shiva; Franc, Benjamin L.; Webb, Emily M.; Chu, Bill; Hawkins, Randall A.; Coakley, Fergus.

In: American Journal of Roentgenology, Vol. 191, No. 5, 11.2008, p. 1436-1439.

Research output: Contribution to journalArticle

Badiee, Shiva ; Franc, Benjamin L. ; Webb, Emily M. ; Chu, Bill ; Hawkins, Randall A. ; Coakley, Fergus. / Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases. In: American Journal of Roentgenology. 2008 ; Vol. 191, No. 5. pp. 1436-1439.
@article{011e07c5005242c7a6dc3b6779ca26df,
title = "Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases",
abstract = "OBJECTIVE. The purpose of our study was to investigate the role of IV iodinated contrast material in the evaluation of hepatic metastases at 18F-FDG PET/CT. MATERIALS AND METHODS. We retrospectively identified 39 patients (25 men and 14 women) with suspected isolated hepatic metastases from colorectal cancer who underwent FDG PET/CT. The CT protocol included acquisition of unenhanced and multiphase contrast-enhanced CT images through the liver. At two separate sittings, four readers (two radiologists and two nuclear medicine physicians) noted and characterized all hepatic lesions in consensus, first based on PET and unenhanced CT images and later based on PET and contrast-enhanced CT images. The nature of detected lesions was established by histopathologic or clinicoradiologic correlation. RESULTS. A total of 178 hepatic lesions were identified, consisting of 137 metastases and 41 benign lesions. Using lesion-based analyses with Obuchowski's method for paired observations, 172 of 178 lesions (97{\%}) were detected at PET/contrast-enhanced CT compared with only 135 of 178 (76{\%}) at PET/unenhanced CT (p = 0.0004). Specifically, 114 of 137 (83{\%}) hepatic metastases were detected on PET/contrast-enhanced CT compared with 92 of 137 (67{\%}) on PET/unenhanced CT (p = 0.012). One hundred thirty-one of 178 lesions (73{\%}) were accurately characterized at PET/contrast-enhanced CT compared with 101 of 178 (57{\%}) at PET/unenhanced CT (p = 0.004). CONCLUSION. IV iodinated contrast material administration improves the detection of hepatic metastases and the characterization of focal hepatic lesions at PET/CT.",
keywords = "F-FDG, Colorectal cancer, Liver, Metastatic liver disease, PET/CT",
author = "Shiva Badiee and Franc, {Benjamin L.} and Webb, {Emily M.} and Bill Chu and Hawkins, {Randall A.} and Fergus Coakley",
year = "2008",
month = "11",
doi = "10.2214/AJR.07.3750",
language = "English (US)",
volume = "191",
pages = "1436--1439",
journal = "AJR. American journal of roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "5",

}

TY - JOUR

T1 - Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases

AU - Badiee, Shiva

AU - Franc, Benjamin L.

AU - Webb, Emily M.

AU - Chu, Bill

AU - Hawkins, Randall A.

AU - Coakley, Fergus

PY - 2008/11

Y1 - 2008/11

N2 - OBJECTIVE. The purpose of our study was to investigate the role of IV iodinated contrast material in the evaluation of hepatic metastases at 18F-FDG PET/CT. MATERIALS AND METHODS. We retrospectively identified 39 patients (25 men and 14 women) with suspected isolated hepatic metastases from colorectal cancer who underwent FDG PET/CT. The CT protocol included acquisition of unenhanced and multiphase contrast-enhanced CT images through the liver. At two separate sittings, four readers (two radiologists and two nuclear medicine physicians) noted and characterized all hepatic lesions in consensus, first based on PET and unenhanced CT images and later based on PET and contrast-enhanced CT images. The nature of detected lesions was established by histopathologic or clinicoradiologic correlation. RESULTS. A total of 178 hepatic lesions were identified, consisting of 137 metastases and 41 benign lesions. Using lesion-based analyses with Obuchowski's method for paired observations, 172 of 178 lesions (97%) were detected at PET/contrast-enhanced CT compared with only 135 of 178 (76%) at PET/unenhanced CT (p = 0.0004). Specifically, 114 of 137 (83%) hepatic metastases were detected on PET/contrast-enhanced CT compared with 92 of 137 (67%) on PET/unenhanced CT (p = 0.012). One hundred thirty-one of 178 lesions (73%) were accurately characterized at PET/contrast-enhanced CT compared with 101 of 178 (57%) at PET/unenhanced CT (p = 0.004). CONCLUSION. IV iodinated contrast material administration improves the detection of hepatic metastases and the characterization of focal hepatic lesions at PET/CT.

AB - OBJECTIVE. The purpose of our study was to investigate the role of IV iodinated contrast material in the evaluation of hepatic metastases at 18F-FDG PET/CT. MATERIALS AND METHODS. We retrospectively identified 39 patients (25 men and 14 women) with suspected isolated hepatic metastases from colorectal cancer who underwent FDG PET/CT. The CT protocol included acquisition of unenhanced and multiphase contrast-enhanced CT images through the liver. At two separate sittings, four readers (two radiologists and two nuclear medicine physicians) noted and characterized all hepatic lesions in consensus, first based on PET and unenhanced CT images and later based on PET and contrast-enhanced CT images. The nature of detected lesions was established by histopathologic or clinicoradiologic correlation. RESULTS. A total of 178 hepatic lesions were identified, consisting of 137 metastases and 41 benign lesions. Using lesion-based analyses with Obuchowski's method for paired observations, 172 of 178 lesions (97%) were detected at PET/contrast-enhanced CT compared with only 135 of 178 (76%) at PET/unenhanced CT (p = 0.0004). Specifically, 114 of 137 (83%) hepatic metastases were detected on PET/contrast-enhanced CT compared with 92 of 137 (67%) on PET/unenhanced CT (p = 0.012). One hundred thirty-one of 178 lesions (73%) were accurately characterized at PET/contrast-enhanced CT compared with 101 of 178 (57%) at PET/unenhanced CT (p = 0.004). CONCLUSION. IV iodinated contrast material administration improves the detection of hepatic metastases and the characterization of focal hepatic lesions at PET/CT.

KW - F-FDG

KW - Colorectal cancer

KW - Liver

KW - Metastatic liver disease

KW - PET/CT

UR - http://www.scopus.com/inward/record.url?scp=55549100585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55549100585&partnerID=8YFLogxK

U2 - 10.2214/AJR.07.3750

DO - 10.2214/AJR.07.3750

M3 - Article

C2 - 18941082

AN - SCOPUS:55549100585

VL - 191

SP - 1436

EP - 1439

JO - AJR. American journal of roentgenology

JF - AJR. American journal of roentgenology

SN - 0361-803X

IS - 5

ER -